About Lumen Bioscience
Lumen Bioscience is a private company based in Seattle, Washington. It has reported $0 raised in five offerings on Form D since November 2019. Its chief executive is Brian Finrow.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Not yet | Apr 1, 2025 | $0of $23.0M target | 0 | — | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Not yet | Nov 19, 2024 | $0of $18.3M target | 0 | — | EquityRule 506(b) | Form D ↗ |
| Not yet | Sep 15, 2023 | $0of $33.0M target | 0 | — | Equity, Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Not yet | Jun 29, 2022 | $0of $50.4M target | 0 | — | EquityRule 506(b) | Form D ↗ |
| Not yet | Nov 12, 2019 | $0of $26.0M target | 0 | — | EquityRule 506(b) | Form D ↗ |
| Total, five offerings | $0 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Lumen Bioscience's Form D filed Apr 1, 2025.
EA
Erik Anderson
Director
ES
Ed Schlect
Director
CB
Craig Behnke
Executive officer
JM
John Morrow
Executive officer
RC
Robert Carlson
Director
ML
Mark Litton
Director
MM
Marcos Milla
Director
EO
Eric Orse
Executive officer
BF
Brian Finrow
Chief Executive Officer and director
JR
James Roberts
Executive officer, director and promoter
Earlier filings also listed Don Schlosser (executive officer, last listed Jun 2022).